Priority You MD may prescribe compounded semaglutide and compounded tirzepatide for eligible patients when medically appropriate. Treatment availability and recommendations depend on each patient’s medical needs, current regulations, and pharmacy availability.

Compounded semaglutide acts on GLP-1 receptors involved in appetite, satiety, digestion, and glucose regulation. It may help patients feel fuller sooner, remain satisfied longer, and reduce appetite as part of a provider-guided weight-management plan.

Compounded tirzepatide acts on both GIP and GLP-1 pathways involved in appetite, satiety, and metabolic regulation. It may be prescribed as part of a comprehensive plan that includes nutritional guidance, physical activity, and ongoing medical monitoring.

No. Compounded medications are not FDA-approved, even when an FDA-approved medication with the same drug name exists. They have not undergone FDA premarket review for safety, effectiveness, or quality

No. Compounded semaglutide and compounded tirzepatide should not be described as generic versions, identical copies, or the same as FDA-approved brand-name medications. They are individually compounded prescription formulations. The FDA has specifically warned businesses against misleading comparisons between compounded GLP-1 products and FDA-approved medications.

Common effects associated with GLP-1–based therapy can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, and indigestion. More serious complications are possible. Your provider will review relevant warnings, medication interactions, and symptoms that require medical attention before treatment begins.

Priority You MD works with trusted, U.S.-based 503A compounding pharmacies that prepare medications pursuant to patient-specific prescriptions and operate under applicable state and federal requirements. Compounded medications are not FDA-approved, and 503A pharmacies are primarily overseen through state pharmacy regulation, with additional federal requirements applying to eligible compounding activities.

Yes. Telehealth appointments may be available for eligible patients. Depending on your medical history, location, and proposed treatment, laboratory testing, a recent physical examination, or an in-person evaluation may be required before medication can be prescribed.

Laboratory testing is not typically needed but may be recommended depending on your symptoms, medical history, and the peptide therapy being considered. Your provider will determine which tests, if any, are appropriate before treatment begins.

esults vary according to the medication, dose, treatment consistency, starting health, nutrition, activity, and individual response. Doses are generally increased gradually when appropriate. Weight loss cannot be guaranteed, and the goal is safe, sustainable progress rather than rapid weight reduction.

Yes. In many cases, peptide therapy can complement hormone optimization and other wellness treatments. Your provider will determine which therapies are appropriate based on your individual medical history and treatment goals.